글로벌 COVID-19 타액 검사 잠재력 시장 - 2028년까지의 산업 동향 및 예측

시장 분석 및 통찰력 : 글로벌 COVID-19 타액 검사 잠재적 시장

Data Bridge Market Research에 따르면, COVID-19 타액 검사 잠재 시장은 2028년까지 4,138.40백만 달러를 차지할 것이며, 2021-2028년 예측 기간 동안 7.23%의 CAGR로 성장할 것으로 분석되었습니다.

COVID-19 타액 검사 항원/항체 검사는 전염성이 있는 사람을 빠르게 식별할 수 있으며, 크루즈선, 비행기, 스포츠 경기장, 대학에 효율적인 검사 방법입니다. 백신 접종과 빠르고 빈번한 검사의 혼합은 팬데믹을 종식시키는 데 유망한 잠재력을 가지고 있습니다.

분자 면봉 기반 SARS-CoV-2 검사에 대한 타임라인 및 확장성 문제는 소비자가 타액 기반 검사/선별 접근 방식으로 전환하도록 유도하는 주요 요인이며, 따라서 시장 성장을 촉진합니다. 원래 균주보다 더 전염성이 강한 것으로 관찰된 남아프리카, 영국, 브라질에서 SARS-CoV-2 변종이 출현하면서 신속한 검사에 대한 필요성이 확고해졌습니다.

일부 국가에서는 공공장소를 방문하는 개인의 종류가 늘어나고 사전 팬데믹 통계에 도달하면서, 무증상 개인으로부터 감염원 전파를 완화하기 위해 신속한 진료소에서 실시하는 COVID-19 검사에 대한 수요가 증가하고 있습니다.

이는 간단하지만 효과적인 타액 기반 검사의 이벤트에 대한 R&D를 증가시켰으며 많은 개발자에게 수익성 있는 기회를 제공할 것으로 예상됩니다. 그러나 면봉 기반 검사 방법의 높은 침투와 방법론적 접근과 관련된 제한은 시장 성장을 방해할 것입니다.

This COVID-19 saliva screening test potential market report provides details of new recent developments, trade regulations, import export analysis, production analysis, value chain optimization, market share, impact of domestic and localised market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, strategic market growth analysis, market size, category market growths, application niches and dominance, product approvals, product launches, geographic expansions, technological innovations in the market. To gain more info on COVID-19 saliva screening test potential Market Contact Data Bridge Market Research for an Analyst Brief, our team will help you take an informed market decision to achieve market growth.

Global COVID-19 Saliva Screening Test Potential Market Scope and Market Size

The COVID-19 saliva screening test potential market is segmented on the basis of location, technology, and mode. The growth amongst these segments will help you analyse meagre growth segments in the industries, and provide the users with valuable market overview and market insights to help them in making strategic decisions for identification of core market applications.

• Based on location, the COVID-19 saliva screening test potential market is segmented into travel stations, sports arenas, entertainment venues, corporate campus environments, universities and colleges, factories and others.
• On the basis of technology, the COVID-19 saliva screening test potential market is segmented into fluorescence-labeled antigen/antibodies testing, RT-PCR and CRISPR-Cas9.
• On the basis of mode, the COVID-19 saliva screening test potential Market is segmented into centralized testing and decentralized testing.

COVID-19 Saliva Screening Test Potential Market Country Level Analysis

The COVID-19 saliva screening test potential market is segmented on the basis of location, technology, and mode.

The countries covered in the COVID-19 saliva screening test potential Market report are U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America.

North America dominates the COVID-19 saliva screening test potential market in terms of market share and market revenue and will continue to flourish its dominance during the forecast period. This is due to the presence of major players, high healthcare expenditure and rising use of technological advance devices in hospitals in this region. Europe on the other hand is projected to exhibit the highest growth rate during the forecast period due to the growing awareness about COVID-19 saliva screening test changing lifestyle, and increasing population in this region.

The country section of the COVID-19 saliva screening test potential market report also provides individual market impacting factors and changes in regulation in the market domestically that impacts the current and future trends of the market. Data points such as consumption volumes, production sites and volumes, import export analysis, price trend analysis, cost of raw materials, down-stream and upstream value chain analysis are some of the major pointers used to forecast the market scenario for individual countries. Also, presence and availability of global brands and their challenges faced due to large or scarce competition from local and domestic brands, impact of domestic tariffs and trade routes are considered while providing forecast analysis of the country data.

Healthcare Infrastructure Growth Installed base and New Technology Penetration

The COVID-19 saliva screening test potential market also provides you with detailed market analysis for every country growth in healthcare expenditure for capital equipment, installed base of different kind of products for COVID-19 saliva screening test potential market, impact of technology using life line curves and changes in healthcare regulatory scenarios and their impact on the COVID-19 saliva screening test potential market. The data is available for historic period 2010 to 2019.

Competitive Landscape and COVID-19 Saliva Screening Test Potential Market Share Analysis

The COVID-19 saliva screening test potential market competitive landscape provides details by competitor. Details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, global presence, production sites and facilities, production capacities, company strengths and weaknesses, product launch, product width and breadth, application dominance. The above data points provided are only related to the companies’ focus related to COVID-19 saliva screening test potential market.

COVID-19 타액 검사 잠재력 시장 보고서에서 다루는 주요 기업으로는 ARUP Laboratories, Vatic Health, MOgene, Psomagen, Inc., DxTerity Diagnostics, Inc., Ambry Genetics, Fluidigm Corporation, Gravity Diagnostics, DNA Genotek, Inc., Quidel Corporation, Abbott, LumiraDX, FluroTech Ltd 등이 있으며, 국내 및 글로벌 기업도 있습니다. 시장 점유율 데이터는 글로벌, 북미, 유럽, 아시아 태평양(APAC), 중동 및 아프리카(MEA), 남미에 대해 별도로 제공됩니다. DBMR 분석가는 경쟁 우위를 이해하고 각 경쟁자에 대한 경쟁 분석을 별도로 제공합니다.

SKU-66592